E-cigarette nicotine delivery: Data and learnings from pharmacokinetic studies

American Journal of Health Behavior

Volumn 41, Issue 1, 2017, Pages 16-32

  Fearon, Ian M ^a   Eldridge, Alison ^a   Gale, Nathan ^a   Shepperd, Christopher J ^a   McEwan, Mike ^a   Camacho, Oscar M ^a   Nides, Mitch ^b   McAdam, Kevin ^a   Proctor, Christopher J ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b Los Angeles Clinical Trials ^*  (United States)

Author keywords

E cigarette; Nicotine; Pharmacokinetics; Vaping

Indexed keywords

NICOTINE;

ADULT; BLOOD; COMPARATIVE STUDY; ELECTRONIC CIGARETTE; FEMALE; HUMAN; MALE; MIDDLE AGED; VAPING;

ADULT; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; VAPING;

EID: 85008324880     PISSN: 10873244     EISSN: 19457359     Source Type: Journal    
DOI: 10.5993/AJHB.41.1.2     Document Type: Article

References (44)

1. Lunell E, Molander L, Ekberg K, et al. Site of nicotine absorption from a vapour inhaler-comparison with cigarette smoking. Eur J Clin Pharm. 2000;55(10):737-741.
2. Rodgman A, Perfetti TA. The Chemical Components of Tobacco and Tobacco Smoke. 2nd ed. Boca Raton, FL: CRC Press; 2013.
3. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994;309(6959):901-911.
4. International Agency for Research on Cancer. IARC Handbook of Cancer Prevention, Volume 11, Reversal of Risk after Quitting Smoking. Geneva, Switzerland: WHO Press; 2007.
5. McNeill A, Munafò MR. Reducing harm from tobacco use. J Psychopharmacol. 2013;27(1):13-18.
6. Stratton K, Shetty P, Wallace R, Bondurant S. Clearing the smoke: the science base for tobacco harm reduction-executive summary. Tob Control. 2001;10(2):189-195.
7. Azzopardi D, Patel K, Jaunky T, et al. Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol Mech Meth. 2016;26(6):477-491.
8. Taylor M, Carr T, Oke O, et al. E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke Toxicol Mech Meth. 2016;26(6):465-476.
9. Margham J, McAdam K, Forster M, et al. Chemical composition of an e-cigarette aerosol: a quantitative comparison with cigarette smoke. Chem Res Toxicol. 2016. doi: 10.1021/acs.chemrestox.6b00188.
10. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139.
11. McRobbie H, Phillips A, Goniewicz ML, et al. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res. 2015;8(9):873-878.
12. Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine-containing products using the MCDA approach. European J Addict Res. 2014;20(5):218-225.
13. McNeil A, Brose LS, Calder R, et al. E-cigarettes: An Evidence Update. A Report Commissioned by Public Health England. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/457102/Ecigarettes-an-evidence-update-a-report- commissioned-by-Public-Health-England-FINAL.pdf. Accessed April 25, 2016.
14. Royal College of Physicians (RCP). Nicotine without Smoke: Tobacco Harm Reduction. London, UL: RCP; 2016. Available at: https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harmreduction-
15. Accessed October 25, 2016.
16. Brown J, Beard E, Kotz D, et al. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109(9):1531-1540.
17. Brose LS, Hitchman SC, Brown J, et al. Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption A survey with a 1-year follow-up. Addiction 2015;110(7):1160-1168.
18. Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control. 2010;19(2):98-103.
19. Digard H, Proctor C, Kulasekaran A, et al. Determination of nicotine absorption from multiple tobacco products and nicotine gum. Nicotine Tob Res. 2013;15(1):255-261.
20. Schroeder MJ, Hoffman AC. Electronic cigarettes and nicotine clinical pharmacology. Tob Control. 2014;23(Suppl 2):ii30-ii35.
21. Caldwell B, Sumner W, Crane J. A systematic review of nicotine by inhalation: is there a role for the inhaled route Nicotine Tob Res. 2012;14(10):1127-1139.
22. St Helen G, Havel C, Dempsey DA, et al. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction. 2016;111(3):535-544.
23. Hajek P, Goniewicz ML, Phillips A, et al. Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine Tob Res. 2015;17(2):175-179.
24. Farsalinos KE, Spyrou A, Tsimopoulou K, et al. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 2014;4:4133.
25. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control. 2010;19(1):87-88.
26. Rennard SI, Glover ED, Leischow S, et al. Efficacy of the nicotine inhaler in smoking reduction: a double-blind, randomized trial. Nicotine Tob Res. 2006;8(4):555-564.
27. Caldwell BO, Crane J. Combination nicotine metered dose inhaler and nicotine patch for smoking cessation: a randomized controlled trial. Nicotine Tob Res. 2016;18(10):1944-1951.
28. Moyer TP, Charlson JR, Enger RJ, et al. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem. 2002;48(9):1460-1471.
29. Vansickel AR, Cobb CO, Weaver MF, et al. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and participantive effects. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1945-1953.
30. Rose JE, Turner JE, Murugesan T, et al. Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics. Exp Clin Psychopharmacol. 2010;18(5):385-394.
31. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and participantive effects in regular users. Psychopharmacology (Berl). 2014;231(2):401-407.
32. Nides MA, Leischow SJ, Bhatter M, et al. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am J Health Behav. 2014;38(2):265-274.
33. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res. 2013;15(1):267-270.
34. Beard E, West R, Michie S, Brown J. Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends. BMJ. 2016;354:i4645.
35. Camenga DR, Kong G, Cavallo DA, Krishnan-Sarin S. Current and former smokers' use of electronic cigarettes for quitting smoking: an exploratory study of adolescents and young adults. Nicotine Tob Res. 2016 Sep 23. pii: ntw248. [Epub ahead of print]
36. Bauld L. Electronic cigarettes and smoking cessation. Nicotine Tob Res. 2016;18(10):1925.
37. Tseng TY, Ostroff JS, Campo A, et al. A randomized trial comparing the effect of nicotine versus placebo electronic cigarettes on smoking reduction among young adult smokers. Nicotine Tob Res. 2016;18(10):1937-1943.
38. Shihadeh A, Eissenberg T. Electronic cigarette effectiveness and abuse liability: predicting and regulating nicotine flux. Nicotine Tob Res. 2015;17(2):158-162.
39. Farsalinos KE, Yannovits N, Sarri T, et al. Protocol proposal for, and evaluation of, consistency in nicotine delivery from the liquid to the aerosol of electronic cigarettes atomizers: regulatory implications. Addiction. 2016;111(6):1069-1076.
40. Yan XS, D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol. 2015;71(1):24-34.
41. Walele T, Sharma G, Savioz R, et al. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: pharmacokinetics. Regul Toxicol Pharmacol. 2016;74:187-192.
42. Farsalinos KE, Spyrou A, Stefopoulos C, et al. Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and na?ve users (smokers). Sci Rep. 2015;5:11269.
43. Ramôa CP, Hiler MM, Spindle TR, et al. Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report. Tob Control. 2016;25(e1):e6-9.
44. Lopez AA, Hiler MM, Soule EK, et al. Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: a preliminary report. Nicotine Tob Res. 2016;18(5):720-723.